Loading...
J. KNIPPER & COMPANY — Itraconazole Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #14 buyer for Itraconazole · $565.7K import value · 35 shipments · UNITED STATES · DGFT Verified
J. KNIPPER & COMPANY is the #14 importer of Itraconazole from India with $565.7K in import value and 35 verified shipments. J. KNIPPER & COMPANY holds a 1.6% market share in Itraconazole imports based in UNITED STATES. The company sources from 1 verified supplier across 11 formulations shipped to 1 country. Overall, J. KNIPPER & COMPANY imports 28 pharmaceutical products worth $68.5M across 14 therapeutic categories.
Verified from 35 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ALEMBIC PHARMACEUTICALS LIMITED | $565.7K | 35 | 100.0% |
J. KNIPPER & COMPANY sources Itraconazole from 1 verified Indian supplier based on 35 customs records. The primary supplier is ALEMBIC PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | AMNEAL PHARMACEUTICALS LLC KY | UNITED STATES | $600.0K | 12 | $50.0K |
| 12 | LIFE PHARMA FZE | UNITED ARAB EMIRATES | $524.2K | 20 | $26.2K |
| 14 | J. KNIPPER & COMPANY ★ | UNITED STATES | $428.8K | 26 | $16.5K |
| 16 | MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $410.1K | 11 | $37.3K |
| 15 | ASCEND LABORATORIES LLC | UNITED STATES | $250.0K | 5 | $50.0K |
J. KNIPPER & COMPANY ranks #14 among 629 Itraconazole importers from India. Average shipment value of $16.5K compared to the market average of $11.6K. The closest competitors by value are AMNEAL PHARMACEUTICALS LLC KY and LIFE PHARMA FZE.
Destination countries from 35 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $565.7K | 35 | 100.0% |
J. KNIPPER & COMPANY imports Itraconazole to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $565.7K.
| Formulation | Value | Shipments |
|---|---|---|
| ITRACONAZOLE CAPS 100MG 30C_AP US | $146.9K | 6 |
| ITRACONAZOLE CAPS 100MG 30C AP USNOS | $114.7K | 9 |
| ITRACONAZOLE CAPS 100MG 30C AP US | $102.4K | 6 |
| ITRACONAZOLE CAPS 100MG 7X4S BL_AP US AS PER INVOICENOS | $44.4K | 3 |
| ITRACONAZOLE CAPSULES 100MG (6264 PACK X30'S CAPS) | $37.7K | 2 |
| ITRACONAZOLE CAPS 100MG 30C AP US (6228X30S CAPS) | $37.5K | 1 |
| ITRACONAZOLE CAPS 100MG 30C AP US (6240X30`S CAPS) | $28.5K | 1 |
| ITRACONAZOLE CAPS 100MG 30C AP US (4944X30`S CAPS)NOS | $27.6K | 3 |
| ITRACONAZOLE CAPSULES 100MG [4380 PACK X30'S CAPS] |
What J. KNIPPER & COMPANY and other importers must comply with to import Itraconazole from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $7.3M worth of Itraconazole through 2,727 shipments from 285 suppliers to 123 countries, serving 629 buyers globally. J. KNIPPER & COMPANY imports $565.7K of this total, accounting for 1.6% of India's Itraconazole exports with 35 shipments from UNITED STATES. This is verified from 35 customs shipment records covering 11 distinct formulations.
J. KNIPPER & COMPANY's average Itraconazole order value is $16.2K per consignment, based on 35 shipments totaling $565.7K. J. KNIPPER & COMPANY is based in UNITED STATES and ranks #14 among all Itraconazole importers from India by value. The company sources from 1 verified supplier in India.
J. KNIPPER & COMPANY sources Itraconazole from 1 verified Indian supplier: ALEMBIC PHARMACEUTICALS LIMITED ($565.7K, 100.0%). This is based on 35 customs records.
J. KNIPPER & COMPANY ranks #14 among 629 Itraconazole importers from India with a 1.6% market share. The top 3 importers are AMNEAL PHARMACEUTICALS, LLC (KY) ($1.3M), NOVAMED FABRICACAO DE PRODUTOS ($950.0K), ACINO PHARMA AG ($676.1K). J. KNIPPER & COMPANY processed 35 shipments from UNITED STATES.
J. KNIPPER & COMPANY also imports these antifungals products. Each links to the detailed product page.
J. KNIPPER & COMPANY imports 28 products worth $68.5M. Beyond Itraconazole, top products include Celecoxib, Losartan, Valsartan, Doxycycline, Azithromycin. View the complete J. KNIPPER & COMPANY profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Itraconazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for J. KNIPPER & COMPANY's Itraconazole imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
J. KNIPPER & COMPANY
Full Company Profile →
28 products · $68.5M total trade · 14 categories
| $13.3K |
| 1 |
| ITRACONAZOLE CAPS 100MG 7X4'S BL_AP US | $10.2K | 2 |
J. KNIPPER & COMPANY imports 11 distinct Itraconazole formulations from India. The top formulation is ITRACONAZOLE CAPS 100MG 30C_AP US with 6 shipments worth $146.9K.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 629+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for J. KNIPPER & COMPANY.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Itraconazole. For current order-level data, contact TransData Nexus.